Rize Oncology Statistics

Total Valuation

Rize Oncology has a market cap or net worth of 12.12 million. The enterprise value is 10.96 million.

Market Cap	12.12M
Enterprise Value	10.96M

Important Dates

The next estimated earnings date is Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Rize Oncology has 75.74 million shares outstanding. The number of shares has increased by 68.71% in one year.

Current Share Class	75.74M
Shares Outstanding	75.74M
Shares Change (YoY)	+68.71%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	87.81%
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	44.68
P/TBV Ratio	44.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.08
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 41.21

Current Ratio	41.21
Quick Ratio	22.51
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -191.89% and return on invested capital (ROIC) is -120.88%.

Return on Equity (ROE)	-191.89%
Return on Assets (ROA)	-117.51%
Return on Invested Capital (ROIC)	-120.88%
Return on Capital Employed (ROCE)	-448.42%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	6,267

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.22M
Pretax Income	-1.21M
Net Income	-1.21M
EBITDA	n/a
EBIT	-1.22M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 151,847 in cash and n/a in debt, with a net cash position of 151,847 or 0.00 per share.

Cash & Cash Equivalents	151,847
Total Debt	n/a
Net Cash	151,847
Net Cash Per Share	0.00
Equity (Book Value)	271,241
Book Value Per Share	0.00
Working Capital	271,241

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.15M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rize Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-68.71%
Shareholder Yield	-68.71%
Earnings Yield	-9.96%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2